A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia
Open Access
- 3 October 2019
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 105 (6) , 1613-1620
Abstract
We present a laboratory-based prognostic calculator (designated CRO score) to risk stratify treatment-free survival in early stage (Rai 0) chronic lymphocytic leukemia developed using a training-validation model in a series of 1,879 cases from Italy, the United Kingdom and the United States. By means of regression analysis, we identified five prognostic variables with weighting as follows: deletion of the short arm of chromosome 17 and unmutated immunoglobulin heavy chain gene status, 2 points; deletion of the long arm of chromosome 11, trisomy of chromosome 12, and white blood cell count>32.0x103/microliter, 1 point. Low, intermediate and high-risk categories were established by recursive partitioning in a training cohort of 478 cases, and then validated in four independent cohorts of 144/395/540/322 cases, as well as in the composite validation cohort. Concordance indices were 0.75 in the training cohort and ranged from 0.63 to 0.74 in the four validation cohorts (0.69 in the composite validation cohort). These findings advocate potential application of our novel prognostic calculator to better stratify early-stage chronic lymphocytic leukemia, and aid case selection in risk-adapted treatment for early disease. Furthermore, they support immunocytogenetic analysis in Rai 0 chronic lymphocytic leukemia being performed at the time of diagnosis to aid prognosis and treatment, particularly in today9s chemo-free era.Keywords
This publication has 50 references indexed in Scilit:
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemiaBlood, 2013
- IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemiaJournal of Translational Medicine, 2012
- Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractorinessBlood, 2011
- Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemiaHematological Oncology, 2011
- Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activationJournal of Experimental Medicine, 2011
- White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemiaHaematologica, 2010
- Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocationHaematologica, 2010
- Validation of a new prognostic index for patients with chronic lymphocytic leukemiaCancer, 2009
- CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potentialBritish Journal of Haematology, 2008
- A clinical staging system for chronic lymphocytic leukemia.Prognostic significanceCancer, 1977